Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Resverlogix Corp (RVX.TO)

Resverlogix Corp (RVX.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 366,020
  • Shares Outstanding, K 209,154
  • Annual Sales, $ 0 K
  • Annual Income, $ -162,798 K
  • 60-Month Beta -0.21
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.57
  • Most Recent Earnings 0.02 on 07/31/19
  • Next Earnings Date 12/12/19
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/19
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +71.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.94 +86.17%
on 10/28/19
1.94 -9.79%
on 11/11/19
+0.65 (+59.09%)
since 10/11/19
3-Month
0.35 +400.00%
on 09/30/19
3.04 -42.43%
on 08/30/19
-1.01 (-36.59%)
since 08/14/19
52-Week
0.35 +400.00%
on 09/30/19
4.94 -64.57%
on 05/08/19
-1.48 (-45.82%)
since 11/14/18

Most Recent Stories

More News
Resverlogix to Hold BETonMACE Conference Call and Webcast on November 18, 2019

Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today announces that it has scheduled a conference call and webcast to supplement the presentation of BETonMACE results to be made during the...

RVXCF : 1.2700 (-4.51%)
RVX.TO : 1.70 (-2.86%)
Resverlogix Announces Voting Results from the 2019 Annual Meeting of Shareholders

Resverlogix Corp. ("Resverlogix", or the "Corporation") (TSX:RVX) today held its Annual Meeting of Shareholders (the "Meeting") in Calgary, Alberta. A total of 66,053,596 shares (approximately 31.54% of...

RVXCF : 1.2700 (-4.51%)
RVX.TO : 1.70 (-2.86%)
Resverlogix Announces US$12 Million Debenture Financing and Full Repayment of Loan

Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today announces that it has issued a 10% secured convertible debenture in the principal amount of US$12 million (the "Debenture") to a wholly-owned...

RVXCF : 1.2700 (-4.51%)
RVX.TO : 1.70 (-2.86%)
Resverlogix to Host BETonMACE Webcast and Conference Call

Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today announces that, in connection with BETonMACE topline results, expected to be announced on September 30, 2019, the company plans to hold...

RVXCF : 1.2700 (-4.51%)
RVX.TO : 1.70 (-2.86%)
Toronto Stock Exchange Introduces the TSX30

Canada's premier equities marketplace launches new program to showcase top performing companies, TSX to host market open ceremony September 27

X.TO : 110.61 (-0.14%)
AC.TO : 49.32 (+0.92%)
APHA.TO : 5.46 (-7.77%)
APY.TO : 3.95 (-0.25%)
BLDP.TO : 8.51 (+3.65%)
CAE.TO : 36.10 (+1.23%)
CJT.TO : 96.73 (-0.99%)
CSU.TO : 1,334.79 (+0.99%)
DOO.TO : 62.19 (+0.32%)
GC.TO : 38.82 (-0.03%)
GCM.TO : 4.83 (+2.11%)
GSY.TO : 64.98 (+0.05%)
IVN.TO : 3.64 (+1.39%)
KL.TO : 63.00 (+0.88%)
LIF.TO : 22.89 (+1.51%)
NEPT.TO : 3.52 (-9.28%)
NOA.TO : 14.88 (+0.54%)
PBL.TO : 19.90 (-1.97%)
PDL.TO : 19.64 (-0.05%)
PLC.TO : 29.61 (+1.06%)
RVX.TO : 1.70 (-2.86%)
SHOP.TO : 418.79 (+0.60%)
TC.TO : 79.25 (+0.76%)
TH.TO : 4.88 (-0.41%)
TMQ.TO : 2.76 (-1.08%)
TVK.TO : 12.25 (+0.41%)
VFF.TO : 8.77 (-6.30%)
WDO.TO : 8.48 (-1.51%)
WEED.TO : 20.27 (-17.10%)
Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association's Scientific Sessions 2019

Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today the Late Breaking Science submission, regarding the primary results of the BETonMACE trial, has been accepted by the American...

RVXCF : 1.2700 (-4.51%)
RVX.TO : 1.70 (-2.86%)
Resverlogix Announces Annual and Special Meeting of Shareholders

Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that its Annual and Special Meeting of Shareholders (the "Meeting") is to be held Thursday, October 31, 2019 at Mount Royal...

RVXCF : 1.2700 (-4.51%)
RVX.TO : 1.70 (-2.86%)
Resverlogix to Present at the European Society of Cardiology's ESC Congress 2019

Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announces today that it will present at ESC Congress 2019, held this year in Paris, France, from August 31 to September 4, 2019, the world's...

RVXCF : 1.2700 (-4.51%)
RVX.TO : 1.70 (-2.86%)
Resverlogix Announces Loan Reduction and Extension

Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today announces that it has entered into an amending agreement with Third Eye Capital (acting as agent for a syndicate of lenders) to extend...

RVXCF : 1.2700 (-4.51%)
RVX.TO : 1.70 (-2.86%)
Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics

Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today the recent publication of an article titled: "Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients...

RVXCF : 1.2700 (-4.51%)
RVX.TO : 1.70 (-2.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 1.98
1st Resistance Point 1.87
Last Price 1.70
1st Support Level 1.65
2nd Support Level 1.54

See More

52-Week High 4.94
Fibonacci 61.8% 3.19
Fibonacci 50% 2.64
Fibonacci 38.2% 2.10
Last Price 1.70
52-Week Low 0.35

See More

Business Summary

Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases....

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar